PDE 2 inhibitors (Boehringer Ingelheim)

N/A

Report date: 2025/06/11 20:01:15
NME

Base Information

Drug NamePDE 2 inhibitors (Boehringer Ingelheim)
Drug Alias NamePDE 2 inhibitors (biocrea)BCA-909BCR-909
ClassificationSmall molecules
Mechanisms of ActionType 2 cyclic nucleotide phosphodiesterases inhibitorsNeuroprotectants
TargetsType 2 cyclic nucleotide phosphodiesterases
Therapy Area/IndicationsCognitive DysfunctionCentral Nervous System Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryGermany
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesBioCrea GmbH
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesBioCrea GmbHBoehringer Ingelheim International Gmbh
Active IndicationsN/A
Inactive IndicationsCognitive DysfunctionCentral Nervous System Diseases

Other Information

ATC CodeN/A
Related LinksN/A